In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
作者信息
Silva-Arrieta Sandra, Goulder Philip J R, Brander Christian
机构信息
IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
出版信息
PLoS Pathog. 2020 Jun 4;16(6):e1008607. doi: 10.1371/journal.ppat.1008607. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.虚拟世界中的真相？基于T细胞表位预测的SARS-CoV-2疫苗开发的潜在局限性。
PLoS Pathog. 2020 Jun 4;16(6):e1008607. doi: 10.1371/journal.ppat.1008607. eCollection 2020 Jun.
2
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.BCG 疫苗可能会产生针对 SARS-CoV-2 的交叉反应性 T 细胞：计算机分析与假设。
Vaccine. 2020 Sep 22;38(41):6352-6356. doi: 10.1016/j.vaccine.2020.08.045. Epub 2020 Aug 20.
3
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.基于表位的新型 SARS-CoV-2 疫苗设计的生物信息学分析。
Infect Dis Poverty. 2020 Jul 10;9(1):88. doi: 10.1186/s40249-020-00713-3.
4
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.基于表位的新型冠状病毒 2019（SARS-CoV-2）肽疫苗的研制：免疫信息学方法。
J Med Virol. 2020 Jun;92(6):618-631. doi: 10.1002/jmv.25736. Epub 2020 Mar 5.
5
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.利用免疫信息学方法探索 SARS-CoV-2 的不可见抗原，设计候选多表位疫苗。
Vaccine. 2020 Nov 10;38(48):7612-7628. doi: 10.1016/j.vaccine.2020.10.016. Epub 2020 Oct 9.
6
Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.利用T细胞免疫开发快速、安全且有效的新冠疫苗。
Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.
7
Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.设计一种能够与多种 HLA 分子相互作用的高效多表位疫苗，以有效诱导体液和细胞免疫应答，预防 COVID-19 感染。
Expert Rev Vaccines. 2020 Sep;19(9):871-885. doi: 10.1080/14760584.2020.1811091. Epub 2020 Sep 24.
8
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.鉴定 SARS-CoV-2 蛋白在南美的新型候选表位：按国家/地区分析 HLA 频率的综述。
Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020.
9
Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.运用免疫信息学方法设计针对新兴冠状病毒病 2019（COVID-19）的多表位疫苗。
Front Immunol. 2020 Jul 10;11:1663. doi: 10.3389/fimmu.2020.01663. eCollection 2020.
10
A vaccine is not too far for COVID-19.针对新冠病毒的疫苗已为时不远。
J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.
引用本文的文献
1
Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances.革新尼帕病毒疫苗学：亚单位疫苗开发策略与免疫学进展洞察
In Silico Pharmacol. 2024 Jul 27;12(2):69. doi: 10.1007/s40203-024-00246-9. eCollection 2024.
2
In vitro identification of neutralizing epitopes of Rhipicephalus microplus serpin 17 (RmS-17).体外鉴定硬蜱丝氨酸蛋白酶抑制剂 17（RmS-17）的中和表位。
Vaccine. 2024 Aug 13;42(20):126161. doi: 10.1016/j.vaccine.2024.126161. Epub 2024 Jul 26.
3
Systems approach to design multi-epitopic peptide vaccine candidate against fowl adenovirus structural proteins for .系统方法设计针对禽腺病毒结构蛋白的多表位肽疫苗候选物。
Front Cell Infect Microbiol. 2024 May 28;14:1351303. doi: 10.3389/fcimb.2024.1351303. eCollection 2024.
4
Immunoinformatics, molecular docking and dynamics simulation approaches unveil a multi epitope-based potent peptide vaccine candidate against avian leukosis virus.免疫信息学、分子对接和动力学模拟方法揭示了一种基于多表位的抗禽白血病病毒高效肽疫苗候选物。
Sci Rep. 2024 Feb 4;14(1):2870. doi: 10.1038/s41598-024-53048-6.
5
Complement System Inhibitory Drugs in a Zebrafish () Model: Computational Modeling.补体系统抑制药物在斑马鱼（）模型中的应用：计算建模。
Int J Mol Sci. 2023 Sep 9;24(18):13895. doi: 10.3390/ijms241813895.
6
Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development.SARS-CoV-2 的免疫学与免疫疗法：用于疫苗开发的免疫原性表位鉴定。
Curr Microbiol. 2022 Sep 5;79(10):306. doi: 10.1007/s00284-022-03003-3.
7
Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.生物信息学在抗击新冠疫情中的应用综合分析。
Comput Biol Chem. 2021 Dec;95:107599. doi: 10.1016/j.compbiolchem.2021.107599. Epub 2021 Nov 2.
8
Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.严重急性呼吸综合征冠状病毒2型感染中的抗原呈递：I类人白细胞抗原和内质网氨肽酶多态性的作用
Hum Immunol. 2021 Aug;82(8):551-560. doi: 10.1016/j.humimm.2021.05.003. Epub 2021 May 10.
9
Multi-epitope-Based Vaccine Designed by Targeting Cytoadherence Proteins of .基于多表位的疫苗，通过靶向……的细胞黏附蛋白设计而成。 （原文此处不完整）
ACS Omega. 2021 May 17;6(21):13742-13755. doi: 10.1021/acsomega.1c01032. eCollection 2021 Jun 1.
10
The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment.生物信息学应用在发现COVID-19治疗候选疫苗和潜在药物中的相关性。
Bioinform Biol Insights. 2021 Mar 15;15:11779322211002168. doi: 10.1177/11779322211002168. eCollection 2021.
本文引用的文献
1
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
2
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.登革热病毒感染中的保护性前暴露细胞因子特征与病理性前暴露细胞因子特征。
PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0006975. doi: 10.1371/journal.pntd.0006975. eCollection 2018 Dec.
3
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.病原体衍生的 HLA-E 结合表位揭示了广泛的主要锚定口袋耐受性和构象可变形的肽结合。
Nat Commun. 2018 Aug 7;9(1):3137. doi: 10.1038/s41467-018-05459-z.
4
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.替代性效应功能分析揭示了在长期高暴露于HIV但未感染个体中广泛的HIV特异性T细胞反应。
J Infect Dis. 2015 Mar 15;211(6):936-46. doi: 10.1093/infdis/jiu534. Epub 2014 Sep 23.
5
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.对HIV感染的T细胞的I类人白细胞抗原（HLA）所呈递的病毒肽进行直接询问。
J Virol. 2014 Nov;88(22):12992-3004. doi: 10.1128/JVI.01914-14. Epub 2014 Aug 27.
6
HLA class I supertypes: a revised and updated classification.HLA I类超型：修订与更新后的分类
BMC Immunol. 2008 Jan 22;9:1. doi: 10.1186/1471-2172-9-1.
7
Extensive HLA class I allele promiscuity among viral CTL epitopes.病毒CTL表位中广泛存在的HLA I类等位基因混杂现象。
Eur J Immunol. 2007 Sep;37(9):2419-33. doi: 10.1002/eji.200737365.
8
Have we cut ourselves too short in mapping CTL epitopes?在绘制细胞毒性T淋巴细胞（CTL）表位图谱时，我们是否做得过于简略了？
Trends Immunol. 2006 Jan;27(1):11-6. doi: 10.1016/j.it.2005.11.001. Epub 2005 Nov 16.
9
HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.单个感染个体中针对两个最佳表位的HLA - B57限制性细胞毒性T淋巴细胞活性，其中一个表位完全包含在另一个表位内。
J Virol. 2000 Jun;74(11):5291-9. doi: 10.1128/jvi.74.11.5291-5299.2000.
10
Zotero 插件